Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Huoxue Huatan granule is a proprietary traditional Chinese medicine (TCM) formulation developed by The First Affiliated Hospital of Naval Medical University (also known as Shanghai Changhai Hospital) for the treatment of polycystic ovary syndrome (PCOS). The formulation is specifically designed for patients categorized under the TCM patterns of kidney deficiency and phlegm-dampness. It aims to restore hormonal balance and improve metabolic function by tonifying the kidney, promoting blood circulation to remove stasis, and resolving phlegm. In clinical trials, such as ChiCTR2000036470, the granule is evaluated both as a monotherapy and in combination with other interventions like acupoint catgut implantation and metformin to optimize treatment outcomes for PCOS-related symptoms, including menstrual irregularity and ovulatory dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Huoxue Huatan granule.